247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

Vaishali Pharma Limited IPO (Vaishali Pharma IPO) Details

Vaishali Pharma Limited is an Pharmaceutical based company, located in Mumbai, Vaishali Pharma Limited IPO size was 14.23 Cr. and was issued at 72.00 per share. The share of Vaishali Pharma Limited were listed at 70.35 per share and are currently trading at 15.54 per share.

Type :
Sub Sector : Company Dealing In Pharmaceutical Formulations
SME IPO
NSE EMERGE

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
67.11 Cr.

PAT :
0.66 Cr.

Pricing Report

Issue Price :
72.00

Listing Price :
70.35

Current Market Price :
15.54

Issue Price vs CMP :
56.46 (78.42%)

listing Price vs CMP :
54.81 (77.91%)

Performance Report (CAGR* wise)

CAGR : -18.66
-ve 0 6 9 12+
Below Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Vaishali Pharma

Company Information
Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgicalproducts, veterinarysupplement. They are operating both in domestic and export markets. In domestic markets, they are majorly into trading of APIs whereas in export markets, they are into trading and marketing of APIs, formulations, surgical products and others. For their export markets, they get the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, they have applied for 186 registrations in 13 countries for some of their products,
Show More
Object of Issue
  • Working Capital requirements
  • General Corporate Purposes

Vaishali Pharma SME IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Aug, 2017
IPO Size :
14.23 Cr.
PE Multiple :
72.00
IPO Registrar:
Bigshare Services Private Limited
Anchor Investors:

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other SME IPOs in Mumbai



AAA Technologies Limited

  Information security audit and consulting

  Mumbai


Peer Companies Of This Sector

FAQs

Vaishali Pharma operates in Pharmaceutical and Company Dealing In Pharmaceutical Formulations. The Issue is listed on NSE EMERGE in Aug, 2017. Vaishali Pharma IPO size was 14.23 Cr. with Issue price of 72.00 .

Vaishali Pharma IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Vaishali Pharma IPO listed at a listing price of 70.35 against the offer price of 72.00.

The current market price of Vaishali Pharma is 15.54.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency